Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 27 for “"Fbdd"”.
-
To Design and Develop Semi-Saturated and Unsaturated Bicyclic Heterocycles for Fragment-Based Drug Discovery (FBDD) Campaigns
The concept of Fragment-Based Drug-Discovery (FBDD) seeks to overcome current issues associated with High-Throughput Screening (HTS) for the identification of novel hits, which are ultimately elaborated into leads and drug candidates. This thesis focuses on the preparation of either novel or …
-
Investigating and exploiting best practices in hit identification and hit to lead chemistry
A fragment-based drug discovery (FBDD) effort was carried out against the enzyme target BCATm. This resulted in elucidation of novel binding interactions against the enzyme. Several series of inhibitors were identified, these are the first known small molecule inhibitors of this enzyme. The …
-
Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions
… two of the first fragment-based drug discovery (FBDD) programmes pursued within our laboratories. In recent years, increased emphasis has been placed on careful control of physicochemical properties in the search for safe and efficacious medicines. FBDD has been proposed as a complementary …
-
Identification, characterization, and optimization of fragment hits against coagulation factor XIIa supported by affinity capillary electrophoresis and biochemical assay
… such inhibitors, fragment-based drug discovery (FBDD) has proven to be a reliable approach. This strategy consists of screening small molecules, called fragments, and employing them as building blocks to generate new chemical entities. The advantage over traditional high-throughput screening …
-
Atropisomeric fragments in drug discovery and probe compound development
… compounds in fragment-based drug discovery (FBDD) and probe compound development. </p> <p>Part I describes the investigation of derivatisation methodologies and fragment growth methodologies to generate axially chiral biarylpyrimidines with high rotational barriers, for potential …
-
The use of structure-based drug design to optimise protein-ligand interactions
… of attrition. Fragment-based drug discovery (FBDD) is a new approach to discovering high quality drug candidates using structure-based design with inherent focus on physicochemical properties. This approach was applied to two biological targets, mitochondrial branched-chain aminotransferase …
-
Fragment hotspot mapping to drive the rational elaboration of fragment screening hits
<p>Fragment-based drug discovery (FBDD) has established itself as a powerful tool for developing probe and drug candidates by rationally elaborating small chemical fragment hits into larger, optimised lead compounds. The use of X-ray crystallography as a medium-throughput screening tool for FBDD …
-
Development of Protein-Observed Fluorine Nuclear Magnetic Resonance Spectroscopy as a Ligand Discovery Technique
Fragment-based drug design (FBDD) has been rapidly gaining traction in the drug discovery process. A central tenant of fragment-based molecular screening is to use less sophisticated small molecules to sample chemical space more efficiently. With Vemurafenib and Venetoclax as FDA approved …
-
Novel Chemotypes for Inhibition of Bacterial and Mammalian Carbohydrate-Binding Proteins
… are required. Fragment-based drug design (FBDD) has proven to be a promising strategy for approaching difficult targets such as lectins. To address the current limitations in design of drug-like inhibitors for lectins, non- and metal-dependent bacterial or mammalian lectins are used. First, …
-
Application of molecular mechanics polarization to fragment based drug design.
… charged species. When studying fragments in FBDD these minor interactions could have large effect in changing how well a ligand will bind to its target. After including the polarizability terms in docking a validation set of ligands (Favia et al., 2011) with GLIDE, it improved the results the …
-
Design and Synthesis of Bivalent Epidermal Growth Factor Receptor Inhibitors for Investigating Molecular Factors of Superadditivity
Fragment-based drug design (FBDD) is a drug development strategy used widely in both industrial and academic drug discovery which has been shown to be an attractive and more accessible alternative to high-throughput screening for generating small-molecule inhibitors. This study focuses on the use …
-
Development of inhibitors for the Bromodomain subfamilies I & IV and for the flavin site of the mitochondrial complex I using in silico fragment-based drug design
… the past vicennial, fragment-based drug design (FBDD) has come forth as a key approach in drug discovery. FBDD relies heavily on structural information mainly acquired through Xray crystallography or NMR. In the absence of such information or to accelerate and guide the design process, …
-
Data-driven approaches to fragment merging
… discovery.</p> <p>Fragment-based drug discovery (FBDD) emerged as an alternative to the more established high-throughput screening, involving the screening of much smaller molecules, typically containing less than 20 heavy atoms, that exhibit higher hit rates and are able to probe the binding site …
-
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL ANTIPROLIFERATIVE COMPOUNDS AS POTENTIAL ANTICANCER AGENTS
… activities. Fragment-based drug design (FBDD) has emerged as promising methodology to generate lead molecules against therapeutic targets in the past decade. Compared with high-throughput screening hits, the advantage is that the identified small molecules are expected to be efficiently …
-
Síntese e otimização guiada por estrutura de fragmentos ligantes da enzima tiorredoxina glutationa redutase de Schistosoma mansoni
… In this work, fragment-based drug discovery (FBDD) strategies were employed, using both fragment linking and fragment growing approaches for the rational design of SmTGR inhibitors. A total of 48 compounds were synthesized, including 39 novel molecules and 9 compounds previously described in …
-
Design of β-lactam Prodrugs to Selectively Suppress β-lactam Resistant, Pathogenic Bacteria in Microbial Mixtures
… combat resistance. A fragment-based drug design (FBDD) platform was developed, validated, and used to design next-generation β-lactam prodrugs capable of selectively suppressing resistant strains. Unlike conventional β-lactam antibiotics, which target penicillin-binding proteins (PBPs), ideal …
-
Desenvolvimento, identificação e modificação estrutural in silico de compostos antitrombóticos inibidores da proteína P2Y12
… strategies, such as Fragment-Based Drug Design (FBDD) and fragment growing techniques. In the context of cardiovascular diseases, membrane-bound therapeutic targets are consolidated as vital for the prevention of severe thrombotic disorders. Aiming at new therapeutic alternatives, the series of …
-
Improvements to Field-Programmable Gate Array Design Efficiency using Logic Synthesis
… (BDD) based logic synthesis flow, referred to as FBDD, where we improve its runtime by several fold with a marginal impact to the resulting circuit area. We do so by speeding up the classical cut generation problem by an order-of-magnitude which enables its application directly at the logic …
-
Structural and Biophysical Characterisation of the Human T-cell Leukaemia Virus 1 Capsid Protein
… the use of fragment-based drug discovery (FBDD) via NMR, and a potential weak binder targeting a sulfate/phosphate binding site was identified. The protein-fragment interacting interface was validated using X-ray crystallography and fragment docking assays. Chapter 5 outlines the strategies …
-
Mechanism Elucidation and Inhibitor Discovery against Serine and Metallo-Beta-Lactamases Involved in Bacterial Antibiotic Resistance
… novel inhibitors using molecular docking and FBDD that would simultaneously inactivate serine β-lactamases and MBLs commonly expressed in Gram-negative pathogenic bacteria. The first project involved examining the structural basis for the class A KPC-2 β-lactamase broad-spectrum of activity …
Page 1 of 2